Levothyroxine sodium

Product NDC: 71335-2562
Requested package NDC: 71335-2562-2
11-digit product format: 713352562
Labeler code: 71335
Product ID: 71335-2562_be577d92-7dbb-48c9-97fe-51ff0cdc44c1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levothyroxine sodium
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA207588
Marketing category: ANDA
Marketing start: 2022-09-21
Substance: LEVOTHYROXINE SODIUM
Active strength: 137 ug/1
Pharmacologic classes: Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A207588-001	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-002	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-003	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-004	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-005	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-006	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-007	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-008	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-009	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-010	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-011	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10
A207588-012	LEVOTHYROXINE SODIUM	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 48 matching rows.

Application-product, TE code table
Application-product	TE code
A207588-001	AB1
A207588-001	AB2
A207588-001	AB3
A207588-001	AB4
A207588-002	AB1
A207588-002	AB2
A207588-002	AB3
A207588-002	AB4
A207588-003	AB1
A207588-003	AB2
A207588-003	AB3
A207588-003	AB4
A207588-004	AB1
A207588-004	AB2
A207588-004	AB3
A207588-004	AB4
A207588-005	AB1
A207588-005	AB2
A207588-005	AB3
A207588-005	AB4
A207588-006	AB1
A207588-006	AB2
A207588-006	AB3
A207588-006	AB4
A207588-007	AB1
A207588-007	AB2
A207588-007	AB3
A207588-007	AB4
A207588-008	AB1
A207588-008	AB2
A207588-008	AB3
A207588-008	AB4
A207588-009	AB1
A207588-009	AB2
A207588-009	AB3
A207588-009	AB4
A207588-010	AB1
A207588-010	AB2
A207588-010	AB3
A207588-010	AB4
A207588-011	AB1
A207588-011	AB2
A207588-011	AB3
A207588-011	AB4
A207588-012	AB1
A207588-012	AB2
A207588-012	AB3
A207588-012	AB4

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 10 · 372 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A207588-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A207588-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207588-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A207588-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-005	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-006	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-007	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-008	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-009	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-010	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-011	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207588-012	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207588-001	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207588-002	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207588-003	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207588-004	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2,AB3,AB4	2022-05-10	`31067a03dcf5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 27 · 1,056 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A207588-001	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-001	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-001	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-001	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-002	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-002	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-002	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-002	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-003	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-003	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-003	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-003	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-004	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-004	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-004	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-004	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-005	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-005	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-005	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-005	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-006	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-006	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-006	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-006	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-007	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-007	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-007	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-007	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-008	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-008	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-008	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-008	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-009	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-009	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-009	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-009	AB4	4	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-010	AB1	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-010	AB2	2	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-010	AB3	3	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207588-010	AB4	4	`84e616aacf4f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Levothyroxine sodium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LEVOTHYROXINE SODIUM	137 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9J765S329G	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
966270	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
702016f6-8507-471f-b833-3a582aef5d2e	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
97c252d3-9bb8-4530-bb44-9824dc7cf556	Product name	6	20250729
6c43b71c-35e6-4db3-ba24-c6ef42ff7003	Product name	3	20240207
890fd4bf-1a80-42b7-be1b-2d0259d5f0c8	Product name	5	20240207
c8ad26bf-af73-460b-b74e-1eff16cc4f9f	Product name	5	20240207
01383843-4069-43cf-aa76-dc17a6f9f8c4	Product name	2	20230123
978cca7d-a938-4791-8322-da48d90a63ef	Product name	1	20230113
65f86ba3-8816-4e12-899b-18290c8de551	Product name	2	20210614
f16ab90f-08c2-40be-a543-66d9827cd1f3	Product name	1	20210601
6a33ec05-2ae2-45e5-ab82-2d94b3303923	Product name	1	20190709
93355a10-1c44-4c92-a11d-7d995e0200d9	Product name	1	20190219

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71335-2562-1	Levothyroxine sodium	30 in 1 BOTTLE	TABLET	30	1
71335-2562-2	Levothyroxine sodium	100 in 1 BOTTLE	TABLET	100	1
71335-2562-3	Levothyroxine sodium	90 in 1 BOTTLE	TABLET	90	1
71335-2562-4	Levothyroxine sodium	28 in 1 BOTTLE	TABLET	28	1
71335-2562-5	Levothyroxine sodium	60 in 1 BOTTLE	TABLET	60	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71335-2562	LEVOTHYROXINE SODIUM TABLET [BRYANT RANCH PREPACK]	1	Current NDC, 5 package rows	20250130_702016f6-8507-471f-b833-3a582aef5d2e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	52a07ade-4098-477d-874e-dd692667041e	2026-03-13	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	64aaeba7-1013-44a4-96fc-b876016897b3	2025-07-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	65b266af-72a5-4409-ab55-bd14341135aa	2025-04-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	A-S Medication Solutions	9ff5ad8e-f28c-4322-be6e-072487878c12	2025-04-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	702016f6-8507-471f-b833-3a582aef5d2e	2025-01-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588 ndc (package): 71335-2562-2 ndc (product): 71335-2562 ndc11 (package): 71335256202
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Preferred Pharmaceuticals Inc.	a55e735f-a5b0-4b85-9fd7-3a4b6723a81b	2024-12-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Bryant Ranch Prepack	e1f77539-2156-4890-baca-8b13779c745c	2024-12-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Proficient Rx LP	b4f8dfd0-b15a-4da5-a0d0-ad768e0b7ff8	2024-09-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588
Levothyroxine sodium	LEVOTHYROXINE SODIUM	Teva Pharmaceuticals, Inc.	60cadfd7-82b5-4207-97e1-1dd0655efb27	2024-06-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207588 application number: ANDA207588

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9J765S329G	LEVOTHYROXINE SODIUM	6106-07-6	LEVOTHYROXINE SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
966270	levothyroxine sodium 137 MCG Oral Tablet	PSN	702016f6-8507-471f-b833-3a582aef5d2e	1
966270	levothyroxine sodium 0.137 MG Oral Tablet	SCD	702016f6-8507-471f-b833-3a582aef5d2e	1
966270	levothyroxine sodium 137 MCG Oral Tablet	SY	702016f6-8507-471f-b833-3a582aef5d2e	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
71335-2562-2	71335256202	100 TABLET in 1 BOTTLE (71335-2562-2)	100 tablet	2025-01-28	No	No	Current